InternationalUSRemember you can easily switch between MIP US and MIP International at any time

India: Novartis fights on in Gleevec battle


Novartis has now appealed to the Supreme Court in a bid to overturn the rejection of its controversial patent for Gleevec. Archana Shanker of Anand and Anand discusses the issues raised by the case

The speculation seemed to have come to an end on June 26 2009 when the Intellectual Property Appellate Board (IPAB) gave its decision on the Novartis patent application directed to the beta crystalline version of imatinib mesylate (Gleevec), refusing the patent application. Novartis then filed a special leave petition (SLP) before the Supreme Court, which has issued notice to the respondents in the matter (Union of India and others) to decide the issue of maintainability.

The facts of the Novartis pre-grant oppositions are well known and this article is only an attempt to summarise the issues and the propositions of law that have been discussed in the judgment.

By way of background, Novartis AG, a Swiss pharmaceutical company, applied for patent number 1602/MAS/1998 claiming Swiss priority of July 18 1997 for an invention directed to a "beta crystalline form of imatinib mesylate". Cancer Patient Aid Association (CPAA), NATCO Pharma, CIPLA...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Why Alibaba's counterfeit spat in China may be a boon for trademark owners - by Peter Leung http://t.co/o5dyxJ1pyy http://t.co/ENrI4QKu4g

Jan 30 2015 12:25 ·  reply ·  retweet ·  favourite
ManagingIP profile

Lessons learned from trademark cases at the #CJEU in 2014 ($) by Alice Stagg of @WraggeLawIP http://t.co/jO4SROxlZg http://t.co/VY4FLfBEOZ

Jan 30 2015 12:14 ·  reply ·  retweet ·  favourite
ManagingIP profile

We've updated our dedicated page on the #UnitaryPatent & #UPC with latest articles (some $) http://t.co/7rhgVzJE0B http://t.co/XazHT7hBef

Jan 30 2015 10:02 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

February 2015

How to survive multinational patent litigation

It’s more and more common for complex IP disputes to involve proceedings in multiple jurisdictions. If you’re preparing for patent litigation take-off, please fasten your seat belt and join James Nurton for a safety demonstration



Most read articles

Supplements